Works matching IS 20406207 AND DT 2017 AND VI 8 AND IP 2
Results: 5
New monoclonal antibodies on the horizon in multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 2, p. 41, doi. 10.1177/2040620716682490
- By:
- Publication type:
- Article
Optimizing current and emerging therapies in multiple myeloma: a guide for the hematologist.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 2, p. 55, doi. 10.1177/2040620716680548
- By:
- Publication type:
- Article
Sweet's syndrome associated with clonal hematopoiesis of indeterminate potential responsive to 5-azacitidine.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 2, p. 91, doi. 10.1177/2040620716680330
- By:
- Publication type:
- Article
Maintenance therapy in multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 2, p. 71, doi. 10.1177/2040620716677244
- By:
- Publication type:
- Article
Emerging role of checkpoint blockade therapy in lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 2, p. 81, doi. 10.1177/2040620716673787
- By:
- Publication type:
- Article